AZD6793
D7860C00006
Phase 2 small_molecule active
Quick answer
AZD6793 for Chronic Obstructive Pulmonary Disease (COPD) is a Phase 2 program (small_molecule) at AstraZeneca with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AstraZeneca
- Indication
- Chronic Obstructive Pulmonary Disease (COPD)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active